FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2471467760> ?p ?o ?g. }

• W2471467760 endingPage "1044" @default.
• W2471467760 startingPage "1031" @default.
• W2471467760 abstract "Increasing evidence suggests that probucol, a lipid-lowering agent with anti-oxidant activities, may be useful for the treatment of ischemic stroke with hyperlipidemia via reduction in cholesterol and neuroinflammation. In this study we examined whether probucol could protect against brain ischemic injury via anti-neuroinflammatory action in normal and hyperlipidemic mice. Primary mouse microglia and murine BV2 microglia were exposed to lipopolysaccharide (LPS) for 3 h, and the release NO, PGE2, IL-1β and IL-6, as well as the changes in NF-κB, MAPK and AP-1 signaling pathways were assessed. ApoE KO mice were fed a high-fat diet containing 0.004%, 0.02%, 0.1% (wt/wt) probucol for 10 weeks, whereas normal C57BL/6J mice received probucol (3, 10, 30 mg·kg-1·d-1, po) for 4 d. Then all the mice were subjected to focal cerebral ischemia through middle cerebral artery occlusion (MCAO). The neurological deficits were scored 24 h after the surgery, and then brains were removed for measuring the cerebral infarct size and the production of pro-inflammatory mediators. In LPS-treated BV2 cells and primary microglial cells, pretreatment with probucol (1, 5, 10 μmol/L) dose-dependently inhibited the release of NO, PGE2, IL-1β and IL-6, which occurred at the transcription levels. Furthermore, the inhibitory actions of probucol were associated with the downregulation of the NF-κB, MAPK and AP-1 signaling pathways. In the normal mice with MCAO, pre-administration of probucol dose-dependently decreased the infarct volume and improved neurological function. These effects were accompanied by the decreased production of pro-inflammatory mediators (iNOS, COX-2, IL-1, IL-6). In ApoE KO mice fed a high-fat diet, pre-administration of 0.1% probucol significantly reduced the infarct volume, improved the neurological deficits following MCAO, and decreased the total- and LDL-cholesterol levels. Probucol inhibits LPS-induced microglia activation and ameliorates cerebral ischemic injury in normal and hyperlipidemic mice via its anti-neuroinflammatory actions, suggesting that probucol has potential for the treatment of patients with or at risk for ischemic stroke and hyperlipidemia." @default.
• W2471467760 created "2016-07-22" @default.
• W2471467760 creator A5003411453 @default.
• W2471467760 creator A5004785796 @default.
• W2471467760 creator A5013722838 @default.
• W2471467760 creator A5022665853 @default.
• W2471467760 creator A5036399753 @default.
• W2471467760 creator A5038657061 @default.
• W2471467760 creator A5040500346 @default.
• W2471467760 creator A5042047712 @default.
• W2471467760 creator A5058591584 @default.
• W2471467760 creator A5084776293 @default.
• W2471467760 date "2016-06-27" @default.
• W2471467760 modified "2023-10-11" @default.
• W2471467760 title "Probucol inhibits LPS-induced microglia activation and ameliorates brain ischemic injury in normal and hyperlipidemic mice" @default.
• W2471467760 cites W1551533003 @default.
• W2471467760 cites W1564983025 @default.
• W2471467760 cites W1921017818 @default.
• W2471467760 cites W1963002584 @default.
• W2471467760 cites W1964814612 @default.
• W2471467760 cites W1966449387 @default.
• W2471467760 cites W1978188576 @default.
• W2471467760 cites W1978859805 @default.
• W2471467760 cites W1981408589 @default.
• W2471467760 cites W1991495749 @default.
• W2471467760 cites W1992310702 @default.
• W2471467760 cites W1994679263 @default.
• W2471467760 cites W1994859901 @default.
• W2471467760 cites W1998106951 @default.
• W2471467760 cites W2005470401 @default.
• W2471467760 cites W2006938639 @default.
• W2471467760 cites W2012221575 @default.
• W2471467760 cites W2012737415 @default.
• W2471467760 cites W2017439349 @default.
• W2471467760 cites W2019554063 @default.
• W2471467760 cites W2027242022 @default.
• W2471467760 cites W2028311105 @default.
• W2471467760 cites W2030782357 @default.
• W2471467760 cites W2032319088 @default.
• W2471467760 cites W2034664125 @default.
• W2471467760 cites W2035319035 @default.
• W2471467760 cites W2047355667 @default.
• W2471467760 cites W2049460970 @default.
• W2471467760 cites W2053922714 @default.
• W2471467760 cites W2064634626 @default.
• W2471467760 cites W2074187719 @default.
• W2471467760 cites W2076034559 @default.
• W2471467760 cites W2086542536 @default.
• W2471467760 cites W2098752487 @default.
• W2471467760 cites W2115968586 @default.
• W2471467760 cites W2117202783 @default.
• W2471467760 cites W2117348440 @default.
• W2471467760 cites W2139018594 @default.
• W2471467760 cites W2142957125 @default.
• W2471467760 cites W2143719958 @default.
• W2471467760 cites W2148763232 @default.
• W2471467760 cites W2151935839 @default.
• W2471467760 cites W2163861774 @default.
• W2471467760 cites W2166615294 @default.
• W2471467760 cites W2167840450 @default.
• W2471467760 cites W2169714544 @default.
• W2471467760 cites W2330609598 @default.
• W2471467760 doi "https://doi.org/10.1038/aps.2016.51" @default.
• W2471467760 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4973385" @default.
• W2471467760 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27345627" @default.
• W2471467760 hasPublicationYear "2016" @default.
• W2471467760 type Work @default.
• W2471467760 sameAs 2471467760 @default.
• W2471467760 citedByCount "37" @default.
• W2471467760 countsByYear W24714677602017 @default.
• W2471467760 countsByYear W24714677602018 @default.
• W2471467760 countsByYear W24714677602019 @default.
• W2471467760 countsByYear W24714677602020 @default.
• W2471467760 countsByYear W24714677602021 @default.
• W2471467760 countsByYear W24714677602022 @default.
• W2471467760 countsByYear W24714677602023 @default.
• W2471467760 crossrefType "journal-article" @default.
• W2471467760 hasAuthorship W2471467760A5003411453 @default.
• W2471467760 hasAuthorship W2471467760A5004785796 @default.
• W2471467760 hasAuthorship W2471467760A5013722838 @default.
• W2471467760 hasAuthorship W2471467760A5022665853 @default.
• W2471467760 hasAuthorship W2471467760A5036399753 @default.
• W2471467760 hasAuthorship W2471467760A5038657061 @default.
• W2471467760 hasAuthorship W2471467760A5040500346 @default.
• W2471467760 hasAuthorship W2471467760A5042047712 @default.
• W2471467760 hasAuthorship W2471467760A5058591584 @default.
• W2471467760 hasAuthorship W2471467760A5084776293 @default.
• W2471467760 hasBestOaLocation W24714677601 @default.
• W2471467760 hasConcept C126322002 @default.
• W2471467760 hasConcept C134018914 @default.
• W2471467760 hasConcept C185592680 @default.
• W2471467760 hasConcept C25498285 @default.
• W2471467760 hasConcept C2776167589 @default.
• W2471467760 hasConcept C2776914184 @default.
• W2471467760 hasConcept C2778163477 @default.
• W2471467760 hasConcept C2778754761 @default.
• W2471467760 hasConcept C2779091943 @default.
• W2471467760 hasConcept C2779830541 @default.

• next